603233 Share Price | DaShenLin Pharmaceutical Group Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

The company has declared Positive results for the last 5 consecutive quarters

ROCE(HY) Highest at 18.11%
INVENTORY TURNOVER RATIO(HY) Highest at 4.59 times
RAW MATERIAL COST(Y) Fallen by -2.39% (YoY)

With ROE of 18.30%, it has a attractive valuation with a 2.14 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 20,210 Million (Large Cap)

P/E

12.00

Industry P/E

Dividend Yield

4.67%

Debt Equity

0.38

Return on Equity

18.30%

Price to Book

2.57

Revenue and Profits:

Net Sales:

7,018 Million

(Quarterly Results - Jun 2026)

Net Profit:

458 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

12.38%

6 Months

5.83%

1 Year

5.03%

2 Years

47.66%

3 Years

-29.34%

4 Years

-37.5%

5 Years

-57.33%

DaShenLin Pharmaceutical Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

12.51%

EBIT Growth (5y)

7.50%

EBIT to Interest (avg)

7.52

Debt to EBITDA (avg)

0.89

Net Debt to Equity (avg)

0.49

Sales to Capital Employed (avg)

1.58

Tax Ratio

26.34%

Dividend Payout Ratio

76.07%

Pledged Shares

Institutional Holding

ROCE (avg)

16.28%

ROE (avg)

16.57%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.14

EV to EBIT

9.67

EV to EBITDA

5.86

EV to Capital Employed

1.83

EV to Sales

0.72

PEG Ratio

0.30

Dividend Yield

5.60%

ROCE (Latest)

18.87%

ROE (Latest)

18.30%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 6.87% vs -0.41% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 27.49% vs 45.27% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,017.80",
          "val2": "6,566.60",
          "chgp": "6.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,092.20",
          "val2": "942.30",
          "chgp": "15.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "43.70",
          "val2": "50.40",
          "chgp": "-13.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.20",
          "val2": "1.20",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "458.20",
          "val2": "359.40",
          "chgp": "27.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "93.10%",
          "val2": "74.00%",
          "chgp": "1.91%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 3.80% vs 8.01% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 38.68% vs -20.38% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27,502.20",
          "val2": "26,496.50",
          "chgp": "3.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,820.00",
          "val2": "3,424.70",
          "chgp": "11.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "217.30",
          "val2": "282.30",
          "chgp": "-23.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-41.70",
          "val2": "-13.10",
          "chgp": "-218.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,358.90",
          "val2": "979.90",
          "chgp": "38.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "73.60%",
          "val2": "57.70%",
          "chgp": "1.59%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]